Abstract
Localization of activated natural killer (A–NK) cells in the microvasculature of growing tumors is the result of recognition of the intracellular and vascular cell–adhesion molecules ICAM–1 and VCAM–1 on the tumor endothelium, mediated by lymphocyte function–associated protein LFA–1 and vascular lymphocyte function–associated protein VLA–4. In vitro and in vivo studies of A–NK cell adhesion to endothelial cells showed that vascular endothelial growth factor (VEGF) promotes adhesion, whereas basic fibroblast growth factor (bFGF) inhibits adhesion through the regulation of these molecules on tumor vasculature. Thus, some angiogenic factors may facilitate lymphocyte recognition of angiogenic vessels, whereas others may provide such vessels with a mechanism that protects them from cytotoxic lymphocytes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Sasaki, A., Melder, R.J., Whiteside, T.L., Herberman, R.B. & Jain, R.K. referential localization of human adherent lymphokine-activated killer cells in tumor microcirculation. J. Natl. Cancer Inst. 53, 433–437 (1991).
Melder, R.J. et al. Imaging of activated natural killer (NK) cells in mice by positron emission tomography (PET): Preferential uptake in tumors. Cancer Res. 53, 5867–5871 (1993).
Melder, R.J., Salehi, H.A. & Jain, R.K. Localization of activated natural killer cells in MCalV mammary carcinoma grown in cranial windows in C3H mice. Microvascular Res. 50, 35–44 (1995).
Melder, R.J., Walker, E., Herberman, R.B. & Whiteside, T.L. dhesion characteristics of human interleukin 2-activated natural killer cells. Cell. Immunol. 132, 177–192 (1991).
Allavena, P. et al. Molecules and structures involved in the adhesion of natural killer cells to vascular endothelium. J. Exp. Med. 173, 439–448 (1991).
Melder, R.J., Munn, L.L., Yamada, S., Ohkubo, C. & Jain, R.K. Selectin- and integrin-mediated T lymphocyte rolling and arrest on TNF-alpha-activated endothelium: Augmentation by erythrocytes. Biophys. J. 69, 2131–2138 (1995).
Jain, R.K. et al. Leukocyte-endothelial adhesion and angiogenesis in tumors. Cancer Metastasis Rev. 15, 195ndash;204 (1996).
Munn, L.L., Melder, R.J. & Jain, R.K. Analysis of cell flux in the parallel plate flow chamber: Implications for cell capture studies. Biophys.J. 67, 889–895 (1994).
Munn, L.L., Koenig, G.C., Jain, R.K. & Melder, R.J. Kinetics of adhesion mole cule expression and spatial organization using targeted sampling fluorometry. BioTechniques 19, 622–631 (1995).
Yuan, F. et al. Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res. 54, 4564–4568 (1994).
Jain, R.K. Determinants of tumor blood flow: A review. Cancer Res. 48, 2641 2648 (1988).
de Fourgerolles, A.R., Stacker, S.A., Schwarting, R. & Springer, T.A. Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1. Exp.Med 174, 253–267 (1991).
Folkman, J. Tumor angiogenesis. in The Molecular Basis of Cancer (eds. Mendelson, J., Howley, P.M. & Liotta, L.A.) 206–232 (Saunders, Philadelphia, 1995).
Fidler, I.J. & Elis, L.M. The implications of angiogenesis for biology and therapy of cancer metastasis. Cell 79, 185–188 (1994).
Jallal, B. et al. Suppression of tumor growth in vivo by local and systemic 90K level increase. Cancer Res. 55, 3223–3227 (1995).
Dvorak, H.F., Brown, L.F., Detmar, M. & Dvorak, A.M. ascular permeability factorJvascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146, 1029–1039 (1995).
Reed, J.A., McNutt, N.S. & Albino, A.P. Differential expression of basic FGF (bFGF) in melanocytic lesions demonstrated by in situ hybridization: Implications for tumor progression. Am. J. Pathol. 144, 329–336 (1994).
Goto, F., Goto, K., Weidel, K. & Folkman, J. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. J.Lab. Invest. 69, 508–517 (1993).
Ferrara, N. Missing link in angiogenesis. Nature 376, 467 (1995).
Koch, A.E., Halloran, M.M., Haskell, C.K., Shah, M.R. & PJ. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 376, 517–519 (1995).
Friedlander, M. et al. Definition of two angiogenic pathways by distinct alpha vintegrins. Science 270, 1500–1502 (1995).
Brooks, P.C. et al. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157–1164 (1994).
Fukumura, D. et al. Tumor necrosis factor alpha-induced leukocyte adhesion in normal and tumor vessels: Effect of tumor type, transplantation site, and host strain. Cancer Res. 55, 4824–4829 (1995).
Ohkubo, C., Bigos, D. & Jain, R.K. IL-2 induced leukocyte adhesion to the normal and tumor microvascular endothelium in vivo and its inhibition by dextran sulfate: Implications for vascular- leak syndrome. Cancer Res. 51, 1561 1563 (1991).
Wu, N.Z., Klitzman, B., Dodge, R. & Dewhirst, M.W. iminished leukocyteendothelium interaction in tumor microvessels. Cancer Res. 52, 4265–4268 (1992).
Osborn, L. Leukocyte adhesion to endothelium in inflammation. Cell 62, 3–6 (1990).
Gamble, J.R., Khew-Goodall, Y. & Vadas, M.A. Transforming growth factor-beta inhibits E-selectin expression on human endothelial cells. J. Immunol. 150, 4494 4503 (1993).
Santambrogio, L. et al. Studies on the mechanisms by which transforming growth factor-beta protects against allergic encephalomyelitis. J. Immunol. 151, 1116–1127 (1993).
Blotnick, S., Peoples, G.E., Freeman, M.R., Eberlein, T.J. & Klagsbrun, M. T lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: Differential production and release by CD4+ and CD8+ T cells. Proc. Natl. Acad. Sci. USA 91, 2890–2894 (1994).
Freeman, M.R. et al. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: A potential role for T cells in angiogenesis. Cancer Res. 55, 4140–4115 (1995).
Dellian, M., Witwer, B.P., Salehi, H.A., Yuan, F. & Jain, R. uantitation and physiological characterization of angiogenic vessels in mice. Am. J. Pathol. 149, 59–71 (1996).
Melder, R.J. & Jain, R.K. Kinetics of interleukin-2 induced changes in rigidity of human natural killer cells. Cell Biophys. 20, 161–176 (1992).
Sasaki, A., Jain, R.K., Maghazachi, A.A., Goldfarb, R.H. & Herberman, R.B. Low deformability of lymphokine-activated killer cells as a possible determinant of in vivo distribution. Cancer Res. 49, 3742–3746 (1989).
Whiteside, T.L. & Goldfarb, R.H. Antitumor effector cells: Extravasation and control of metastasis. Immunol. Ser. 61, 159–173 (1994).
Melder, R.J. et al. Cytotoxic activity against HIV infected monocytes by recombinant interleukin 2-activated natural killer cells. AIDS Res. Hum. Retrovir. 6, 1011–1015 (1990).
Kitayama, J. et al. Lysis of endothelial cells by autologous lymphokine-activated killer cells. Cancer Immunol. Immunother. 38, 317–322 (1994).
Watson, C.A., Camera-Benson, L., Palmer-Crocker, R. & Pober, J.S. ariability among human umbilical vein endothelial cultures. Science 268, 447–448 (1995).
Gullino, P.M. Techniques in tumor pathophysiology. in Methods in Cancer Research (ed. Busch, H.) 45–92 (Academic Press, New York, 1970).
Melder, R.J., Whiteside, T.L., Vujanovic, N.L., Hiserodt, J.C. & Herberman, R.B. A new approach to generating antitumor effectors for adoptive immunotherapy using human adherent lymphokine-activated killer cells. Cancer Res. 48, 3461–3469 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Melder, R., Koenig, G., Witwer, B. et al. During angiogenesis, vascular endothelial growth factor regulate natural killer cell adhesion to tumor endothelium. Nat Med 2, 992–997 (1996). https://doi.org/10.1038/nm0996-992
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nm0996-992
This article is cited by
-
Secured delivery of basic fibroblast growth factor using human serum albumin-based protein nanoparticles for enhanced wound healing and regeneration
Journal of Nanobiotechnology (2023)
-
Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions
Signal Transduction and Targeted Therapy (2023)
-
Pathological angiogenesis: mechanisms and therapeutic strategies
Angiogenesis (2023)
-
ESMO 2022: spotlight on new emerging treatment options in central nervous system tumors
memo - Magazine of European Medical Oncology (2023)
-
Proinflammatory activity of VEGF-targeted treatment through reversal of tumor endothelial cell anergy
Angiogenesis (2023)